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Abstract
Background: Childhood immunisation is recognised worldwide as an essential component of health systems and
an indispensable indicator of quality of care for vaccine-preventable diseases. While performance of immunisation
programmes is more commonly measured by coverage, ensuring that every child is immunised at the earliest/
appropriate age is an important public health goal. This study therefore set out to determine the pattern and
predictors of Bacille de Calmette-Guérin (BCG) immunisation delays in the first three months of life in a Sub-
Saharan African community where BCG is scheduled at birth in order to facilitate necessary changes in current
policy and practices for improved services.
Methods: A cross-sectional study in which immunisation delays among infants aged 0-3 months attending
community-based BCG clinics in Lagos, Nigeria over a 2-year period from July 2005 to June 2007 were assessed by
survival analysis and associated factors determined by multivariable logistic regression. Population attributable risk
(PAR) was computed for the predictors of delays.
Results: BCG was delayed beyond three months in 31.6% of all eligible infants. Of 5171 infants enrolled, 3380
(65.4%) were immunised within two weeks and a further 1265 (24.5%) by six weeks. A significantly higher
proportion of infants born in hospitals were vaccinated in the first six weeks compared to those born outside
hospitals. Undernourishment was predictive of delays beyond 2 and 6 weeks while treated hyperbilirubinaemia was
associated with decreased odds for any delays. Lack of antenatal care and multiple gestations were also predictive
of delays beyond 6 weeks. Undernourishment was associated with the highest PAR for delays beyond 2 weeks
(18.7%) and 6 weeks (20.8%).
Conclusions: BCG immunisation is associated with significant delays in this setting and infants at increased risk of
delays can be identified and supported early possibly through improved maternal uptake of antenatal care.
Combining BCG with subsequent immunisation(s) at 6 weeks for infants who missed the BCG may be considered.
Introduction
Tuberculosis (TB) caused by the Mycobacterium tuber-
culosis, is a major disease of great public health concern
affecting about 13.7 million people globally [1]. Asia and
Africa accounted for 55% and 31% of the estimated 9.3
million new cases in 2007 with India, China, Indonesia,
Nigeria and South Africa ranking as the top five leading
countries worldwide. In fact, 13 of the 15 countries with
the highest incidence rates are in Africa led by Nigeria
with estimated 460,000 new cases per year [1].
Bacille Calmette-Guérin (BCG) vaccination is highly
effective in preventing childhood TB, principally miliary
disease and meningitis [2]. BCG immunisation has also
been found to be protective of other mycobacterial
infections such as leprosy, Buruli ulcer and glandular
disease [2]. It is currently one of the most widely admi-
nistered vaccines in infancy and has been shown to be
most cost-effective particularly in low-income countries
where TB is endemic [3]. Each year, more than 100 mil-
lion children are immunised with BCG worldwide [3]
and coverage in Africa currently stands at 89% com-
pared to 16% in 1980, similar to the global pattern over
the same period [4]. However, the regional or global
estimates of coverage hardly reflect the trends accurately
in countries with high disease burden. For example, the
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up from about 23% in 1980 [4]. Similarly, national esti-
mates often mask significant variations within each
country thus undermining the effectiveness of interven-
tion programmes.
Additionally, there is a growing awareness on the lim-
itation of evaluating the performance of immunisation
programmes solely on the basis of coverage irrespective
of the age at which immunisation is given as well as the
need to establish the pattern and determinants of delays
[5-8]. For instance, the current immunisation schedule
recommended by the World Health Organisation and
widely implemented in developing countries is aimed at
providing effective protection at the earliest possible age
[9]. Under this schedule, BCG is due at birth or shortly
thereafter in order to ensure adequate protection against
TB. However, significant delays between the recom-
mended and the actual time of BCG immunisation in a
high proportion of infants in developing countries
besides the substantial variation in adherence to recom-
mended schedules within and across countries have
been reported [8]. Perhaps of greatest concern are delays
in immunisations scheduled at birth due to their poten-
tial for snowballing into subsequent immunisations with
an added risk of outright default [6,10-12]. Such delays
are also likely to undermine the effectiveness of immu-
nisation platforms for implementing integrated child
health interventions as currently encouraged in develop-
ing countries where a high proportion of infants are
born outside hospitals [13,14].
Understanding the multi-dimensional determinants of
delays is crucial in improving services for routine immu-
nisation in any community [5-7]. For instance, while
vaccine shortages or supply-related problems may result
in delays in immunisation, the vast majority of reported
delays particularly in developing countries are attributa-
ble to uptake of services [8]. However, existing evidence
on timeliness of BCG immunisation in Africa is limited
by sample size, methodology and scope of factors stu-
died [15,16]. This community-based study therefore set
out to determine the pattern and associated factors for
delays in BCG immunisation among infants ≤3m o n t h s
old in one of the leading contributors to regional and
global burden of TB. It was hypothesized that determi-
nants of a 3-month delay in this population was likely
to be similar to delays beyond 3 months.
Methods
Study design and population
This cross-sectional study is based on a retrospective
analysis of a previously reported prospective universal
infant hearing screening (UIHS) programme implemen-
ted in an inner-city area of Lagos, southwest of Nigeria,
with an estimated population of 250,000 [17]. At the
time of this study, the community was served by one
general hospital, one children’s hospital, one specialist
maternity hospital and seven primary healthcare centres
all of which are State-owned as well as several private
hospitals and traditional maternity homes. The study
participants consisted of all mother-infant pairs attend-
ing four of the seven community-health centres which
administered routine BCG immunisation over a two-
year period from July 2005 to June 2007 for which
requisite data was available. Under the primary UIHS
project, all infants older than three months were not
enrolled because of the difficulty of conducting electro-
physiological auditory brainstem response screening test
in this age group in a community-based setting. At the
commencement of this study routine immunisation in
the first 3 months in this location consisted of BCG at
birth, followed by diphtheria, pertussis and tetanus
(DPT)1, at 6 weeks; DPT2, at 10 weeks; and DPT3, at
14 weeks. Oral polio (OPV) and hepatitis B (HB) were
subsequently introduced from birth in the course of this
study. The uptake for BCG immunisation was typically
well over 90% in most parts of southern Nigeria com-
pared to the national average of 69% [18,19]. The four
immunisation clinics chosen accounted for over 75% of
BCG vaccinations in this study location. Ethical approval
was obtained from the Lagos State Health Management
Board, Nigeria and University College London, UK [17].
Informed consent was obtained from the mothers of all
participating infants in writing or by thumb printing.
Study variables
The primary outcome measure was the age of each
infant at the time of visit to the clinic for BCG immuni-
sation. This was determined by difference in the date of
visit and the date of birth as reported by the mother.
Each child was enrolled on the same day they received
the vaccination. The explanatory variables consisted of
maternal socio-demographic factors such as age, marital
status, ethnicity, religion, education, occupation, spouses’
occupation and social class as well as obstetric factors
such as parity, antenatal care, place and mode of deliv-
ery. Social classes served as proxy for socio-economic
status and were determined based on mother’s educa-
tion and father’s occupation as previously validated in
this population [20]. Social class I was termed as “high”,
II and III as “middle” and IV or V as “low”.P l a c eo f
delivery consisted of hospitals (public and private) as
well as non-hospitals which included traditional mater-
nity homes (usually run by birth attendants without for-
mal professional training), family homes, church
premises and before arrival in hospital. Infant factors
included gender, gestational age, gestational type (single-
ton or one of twins/triplets), birth order, history of
severe neonatal jaundice (requiring phototherapy and/or
exchange blood transfusion), record of illness requiring
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nutritional status. Anthropometric measurements for
each child were obtained at the time of enrolment by a
trained research worker throughout the study period.
Weight was measured with a digital scale (TANITA
Baby Scale, Model 1583; Tanita Corporation, Tokyo,
Japan). Length was measured supine using graduated
polyurethane plastic mats (Child Growth Foundation,
London, UK). Gender-specific z-scores for weight-for-
age (WAZ), body mass index-for-age (BMI) and height/
length-for-age (HAZ) expressed as z-scores were
obtained from the World Health Organisation’sM u l t i -
centre Growth Reference (WHO-MGR) package using
the macro provided by the organisation [21]. Moderate-
to-severe or “significant” wasting, underweight and
stunting were defined as zBMI, WAZ and HAZ below
-2 respectively. The default settings in the software
regarding cut-offs for out-of-range or biologically
improbable values were used in the data analysis and all
such values were recorded as missing data. Birth weight
and length could not be ascertained as birth records of
the participants particularly those born outside hospitals
were not available in this community-based setting.
Statistical analysis
In order to determine the degree of delay, the age at
immunisation was expressed to the nearest week and
categorised into three groups for the purpose of this
study. The first group termed “age-appropriate” con-
sisted of infants immunised within the first 2 weeks of
birth, making allowance for a grace period of approxi-
mately 2 weeks based on the median delay of 2.3 weeks
for 45 developing countries recently reported [8]. While
all immunisations beyond 2 weeks were considered as
delayed, infants who were immunised after 6 weeks
were further grouped as “significantly” delayed based on
due date for DPT1. The Kaplan-Meier method is an
appropriate technique for analysing time-to-event data
and was used to quantify the proportion of infants
immunised across each specific age. Coverage at age t
was estimated by the survival function: 1 - SKM(t), where
1-SKM(t) is the cumulative probability of being immu-
nised by age t [6]. In order to determine the possible
impact of place of delivery on coverage, immunisation
uptake among infants born in hospitals, traditional
maternity homes, family homes and others (church pre-
mises or born before arrival) were assessed by the log-
rank (Mantel-Cox) test. Although requisite individual
i n f o r m a t i o no ni n f a n t so l d e rt h a n3m o n t h sw h o
received BCG immunisation was not available, the pat-
tern of delays in the first three months of life was
further analysed within the context of the available
records from the local health authorities on the total
population of infants who received BCG immunisation
over the study period.
In establishing the determinants of delays among the
enlisted infants in this study, all continuous explanatory
variables were first expressed as categorical variables.
Thereafter, the bivariate relationship between each
explanatory variable and the timing of immunisation
was assessed with Pearson’s chi-square test. Strength of
association between variables was estimated by odds
ratios (OR) and the corresponding 95% confidence
intervals (CI). All tests of significance were two-sided. In
order to determine predictors for immunisation delays,
maternal and infant factors with significance (p < 0.05)
in bivariate analyses were considered as eligible for
inclusion into two separate multivariable logistic regres-
sion models. The first model compared infants immu-
nised by 2 weeks with those immunised after 2 weeks
while the second model compared infants immunised by
6 weeks with those immunised after 6 weeks of birth. In
each model, non-significant factors (p ≥ 0.05) were
eliminated by backward stepwise method. Interaction
effects of variables in each model were assessed with
likelihood ratio test. Crude estimate of model calibration
was determined by the Hosmer-Lemeshow test. Popula-
tion attributable risk (PAR) for each factor in the final
model was computed with the formula Pe(OR - 1)/OR,
where Pe is the percentage of infants with immunisation
delays exposed to the factor [22]. SPSS for Windows
version 16.0 (SPSS Inc, Chicago, IL, USA) was used for
all statistical analyses.
Results
A total of 5171 mother-infant pairs were enrolled over the
study period and represented 68.9% of all BCG immunised
infants (7506) in the first year of life based on records
from the local health authorities. Infants rarely presented
for BCG immunisation after one year in this population as
only 56 (0.7%) were so reported over the entire period of
this study and were excluded because BCG is usually not
recommended by WHO at this age. Of all immunised
infants ≤1 year old, 50.1% were age-appropriate and 62.9%
were immunised by 6 weeks (Figure 1). Of the 5171
enrolled for this study, delivery in hospitals accounted for
48.6%, traditional maternity homes 39.5%, family homes
6.3%, and others 5.6%. None of the eligible mothers with-
held consent to participate in this study. The median age
of the infants at enrolment was 11 days (inter-quartile
range: 5 - 19 days). In all 3380 (65.4%) infants were immu-
nised in the first 2 weeks, 1265 (24.5%) between 2 - 6
weeks and 526 (10.2%) after 6 weeks.
The proportion of infants ≤3 months old vaccinated
each week across the place of delivery is shown in Fig-
ure 2. The log-rank test (p = 0.029) indicated that there
were significant variations in the age of immunisation
among the four groups of infants based on place of
birth when unadjusted for potential confounding factors.
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Figure 2 Proportion of infants aged 0 - 3 months that received BCG immunisation in Lagos, Nigeria (n = 5171).
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immunisation was among hospital deliveries and the
least proportion came from infants delivered in church
premises or before arrival in hospitals. There was a
sharp increase from birth till two weeks of age, with at
least 65% coverage regardless of the place of delivery.
U s i n gab e n c h m a r ko f8 5 % ,t h e r ew a sa tl e a s t4w e e k s
delay from birth in this cohort. The longest delay from
birth was potentially 52 weeks or 50 weeks from the
age-appropriate limit of 2 weeks based on the data from
the health authorities.
Maternal and infant characteristics are presented in
Tables 1 and 2. Mean age of mothers was 27.93 ± (SD:
5.18 years). As previously reported, the vast majority of
mothers belonged to the middle or high social class but
over half (51.7%) delivered outside hospital facilities.
More than one-third (39.2%) had formal full or part
time employment and 2.1% did not attend antenatal
care for the current delivery. The vast majority (98.3%)
of the infants were born at term (≥37 weeks) and 5.8%
had a history of severe neonatal jaundice. Some one
third (37.4%) were undernourished by at least one mea-
sure of nutritional deficit.
In the bivariate analyses, maternal education, occupa-
tion, place of delivery, mode of delivery, infant hospitali-
sation in the first month of life, severe neonatal jaundice
and undernourished physical state were significantly
associated with delays beyond 14 days but only under-
nourishment emerged as predictor after multivariable
logistic regression with a PAR of 18.7% (Table 3). Mode
of delivery and severe neonatal jaundice were associated
with decreased odds for delays. The logistic model did
not show any evidence of poor calibration (Hosmer-
Lemeshow test: c
2 =3 . 1 6 ,d f=5 ,p=0 . 6 7 6 ) .S i m i l a r l y ,
maternal occupation, lack of antenatal care, multiple
gestations, preterm birth, severe neonatal jaundice and
undernourishment were significantly associated with
delays beyond 42 days in the bivariate analyses and all
factors except preterm birth were predictive of delays
after multivariable logistic regression. Lack of antenatal
care, multiple gestations and undernourishment were
associated with increased odds for delays while formal
employment and severe neonatal jaundice were asso-
ciated with deceased odds for delays. Undernourishment
was also associated with the highest PAR (20.8%). The
logistic model was well calibrated (Hosmer-Lemeshow
test: c
2 = 2.26, df = 6, p = 0.894) and no significant
interactions were found among the variables included in
both logistic regression models.
Additionally, infants with immunisation delays beyond
6 weeks had at least three-fold increased odds of being
at risk of sensorineural hearing loss and two-fold
increased odds of dropping out of a multi-stage hearing
screening programme (data not shown).
Discussion
A unique feature of this study besides the large sample
size compared to similar studies particularly from devel-
oping countries is the recruitment of infants at the
point of receiving immunisation over an extended per-
iod rather than a retrospective audit of clinical records
or survey of patient cards [6,15,16]. The findings from
this study corroborate the existing evidence from both
developed and developing countries on the misrepresen-
tation associated with the evaluation of the performance
of immunisation programmes solely on the basis of
attained coverage. Remaining appropriately immunised
in an endemic region like Sub-Saharan Africa lowers the
risk of infection and possible disease outbreak. The
magnitude of the delays for an immunisation like BCG
scheduled for birth is therefore obviously worrisome
considering that the observed delays for example could
not be justified even on the basis of the revised guide-
lines for communities where HIV is highly prevalent
because HIV-infected infants are usually not sympto-
matic at birth [23]. Moreover, infants immunised late in
this population were not only susceptible to tuberculosis
in an environment with beleaguered and poorly-
resourced health care systems but were also at substan-
tial risk of delayed protection against other vaccine pre-
ventable diseases under subsequent immunisations. In
addition, such delays were likely to undermine the effec-
tiveness and attractiveness of BCG immunisation clinics
as an alternative platform for conventional hospital-
based newborn screening programmes in communities
particularly in Sub-Saharan Africa and South Asia where
a high proportion of babies are delivered outside hospi-
tals [13,24,25]. Evidently, more attention is warranted to
address the determinants of delays for childhood immu-
nisation to optimise the value of the current huge
investments on provision of free vaccines in developing
countries.
A recent study in South Africa has suggested a possi-
ble shift in the timing of BCG from birth to 10 weeks
because of the potential for enhanced memory CD4 T
cell response in later years [ 2 6 ] .B u tt h ea v a i l a b l ee v i -
dence is too limited to justify a revision of the current
national immunisation schedule in Africa or other
developing countries in the immediate future. Combin-
ing BCG with DPT1 at 6 weeks for those who missed
BCG would appear as one approach to improve cover-
age and minimise the snowballing effects with subse-
quent immunisations [6,12]. However, this practice was
n o tc o m m o ni nt h ec u r r e n ts t u d yl o c a t i o np r i m a r i l yf o r
logistical reasons except on national immunisation days
when opportunities were provided for any missed
immunisations. It may therefore be necessary to seek
ways of eliminating or minimising the existing
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Maternal factors Total Timing of BCG immunisation
n = 5171 1 - 14 days
n = 3380
15 - 42 days
n = 1265
After
42 days
n = 526
Age (Years)
a
< 20 173 118 (68.2) 42 (24.3) 13 (7.5)
20 - 35 4538 2972 (65.5) 1109 (24.4) 457 (10.1)
> 35 448 281 (62.7) 111 (24.8) 56 (12.5)
Marital status
Married 5001 3272 (65.4) 1214 (24.3) 515 (10.3)
Not married 170 108 (63.5) 51 (30.0) 11 (6.5)
Ethnicity
Non-Yoruba 519 341 (65.7) 113 (21.8) 65 (12.5)
Yoruba 4652 3039 (65.3) 1152 (24.8) 461 (9.9)
Religion
Muslim 3418 2230 (65.2) 859 (25.1) 329 (9.6)
Christianity 1753 1150 (65.6) 406 (23.2) 197 (11.2)
Education
None 145 78 (53.8) 49 (33.8) 18 (12.4)
Primary/Secondary 4191 2735 (65.3) 1041 (24.8) 415 (9.9)
Post-secondary 835 567 (67.9) 175 (21.0) 93 (11.1)
Occupation
None 709 476 (67.1) 146 (20.6) 87 (12.3)
Small/petty trade 2436 1518 (62.3) 656 (26.9) 262 (10.8)
Formal employment 2026 1386 (68.4) 463 (22.9) 177 (8.7)
Social class
High 340 231 (67.9) 67 (19.7) 42 (12.4)
Middle 4010 2624 (65.4) 994 (24.8) 392 (9.8)
Low 821 525 (63.9) 204 (24.8) 92 (11.2)
Parity
1 2139 1421 (66.4) 491 (23.0) 227 (10.6)
2-4 2827 1842 (65.2) 715 (25.3) 270 (9.6)
>4 205 117 (57.1) 59 (28.8) 29 (14.1)
Antenatal care
One or more visits 5061 3314 (65.5) 1242 (24.5) 505 (10.0)
None 110 66 (60.0) 23 (20.9) 21 (19.1)
Place of delivery
Hospital 2513 1697 (67.5) 545 (21.7) 271 (10.8)
Traditional maternity home 2042 1323 (64.8) 535 (26.2) 184 (9.0)
Family home 327 189 (57.8) 97 (29.7) 41 (12.5)
Church premises/others 289 171 (59.2) 88 (30.4) 30 (10.4)
Mode of delivery
Vaginal 4902 3149 (64.2) 1246 (25.4) 507 (10.3)
Caesarean 269 231 (85.9) 19 (7.1) 19 (7.1)
a Missing data = 12 (0.2%).
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for infants who missed BCG when DPT1 is
administered.
Direct comparison of delays in this study with similar
studies in the literature was somehow hampered by the
variations in the age profile of the subjects and the
expanded scope beyond BCG immunisation. Perhaps the
most relevant study of interest is the recent report by
Clark and Sanderson [8]. For instance, while it was not
possible to determine the median delay for the entire
population of infants who received BCG in this commu-
nity, the median delay among the study participants of 2
weeks compared favourably with the estimate of 2.3
weeks for developing countries or 2.7 weeks for Nigeria.
In addition, the age-specific coverage showed substantial
improvements over the reported national rates for
Nigeria [8]. For example, BCG coverage at 4 weeks and
12 weeks was 59% and 68% respectively compared to
the reported national estimates of 27% and 41%. One
possible reason for these differences is that the current
study was conducted in southern Nigeria where uptake
of childhood immunisation is substantially higher than
in northern Nigeria [27]. There are several ongoing
initiatives supported by prominent developmental agen-
cies to improve the immunisation rates in northern
Nigeria and evidence such as provided by this study
underscores the need to emphasise improved timelines
in uptake besides the overall coverage.
Some of the prominent risk factors in this study are
rarely reported possibly because of the younger age pro-
file and method of recruitment for this study compared
with similar studies [5,6,8,15,28,29]. For instance, the
protective effect of treated neonatal hyperbilirubinaemia
is unlikely to be detected or of interest in studies among
older infants. A possible explanation for the finding in
this study is that mothers of infants who had received
phototherapy or exchange blood transfusion were likely
to be jolted by such an early experience of a potentially
fatal/disabling illness to promptly embrace any recom-
mended protective measure against future illness or
Table 2 Characteristics and timing of infants aged 0-3 months attending BCG immunisation clinics
Infant factors Total Timing of BCG immunisation
n = 5171 1 - 14 days
n = 3380
15 - 42 days
n = 1265
After 42 days
n = 526
Gender
Male 2669 1711 (64.1) 677 (25.2) 281 (10.5)
Female 2502 1669 (66.7) 588 (23.5) 245 (9.8)
Gestational age
a
Full term 5083 3326 (65.4) 1249 (24.6) 508 (10.0)
Preterm 81 53 (65.4) 14 (17.3) 14 (17.3)
Gestational type
Singleton 5077 3324 (65.5) 1244 (24.5) 509 (10.0)
One of twins/triplets 94 56 (59.6) 21 (22.3) 17 (18.1)
Birth order
First child 2139 1421 (66.4) 491 (23.0) 227 (10.6)
Second child or other 3032 1959 (64.6) 774 (25.5) 299 (9.9)
Neonatal jaundice
None 4873 3158 (64.8) 1200 (24.6) 515 (10.6)
Yes 298 222 (74.5) 65 (21.8) 11 (3.7)
Hospitalisation for other illness
No 4939 3179 (64.4) 1251 (25.3) 509 (10.3)
Yes 232 201 (86.6) 14 (6.0) 17 (7.3)
Nutritional status
b
Not undernourished 3219 2247 (69.8) 705 (21.9) 267 (8.3)
Undernourished* 1933 1122 (58.0) 555 (28.7) 256 (13.2)
Missing data: 7 (0.1%)
a, 19 (0.4%)
b. *Any undernourished physical state based on z-scores for weight-for-age, height/length-for-age or body-mass-index of less
than -2 singly or in combination, using WHO 2006 Growth Standards.
21
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was a consistent predictor of BCG immunisation timeli-
ness in the first three months of life. Perhaps more nota-
ble is the consistent predictive utility of an infant’s
nutritional status for BCG immunisation delays which
accords with available limited reports from other
resource-poor countries on default among older infants
[30,31]. Since nutritional status is often a more powerful
index of socio-economic status than social class the find-
ing in this study thus appears to be consistent with stu-
dies that have established family income status/poverty
as predictors of immunisation delays in developed and
developing countries [5,15,28,32]. The findings on hyper-
bilirubinaemia and any undernourished physical state as
consistent predictors of delays in the first three months
of life therefore seems to validate the ap r i o r ihypothesis
that these factors were likely to remain significant in
older infants. For instance, one study from Brazil sug-
gested similar immunogenicity of BCG vaccine in term
infants aged 0-6 months with and without intrauterine
growth restriction [33]. Moreover, the effects of undernu-
trition are likely to become more pronounced in late
infancy and early childhood particularly due to poverty
induced protein-energy deficiencies. However, the exact
relationship between nutritional status and immunisation
delays from early infancy merits further investigation
considering the high burden of childhood undernutrition
in this region [25]. In addressing this problem, it may be
helpful for instance to ascertain if the delay for an under-
nourished child is attributable to parental decision and/
or an advice from health workers.
Lack of antenatal care is an established index of poor
maternal health-seeking behaviour with diverse adverse
perinatal outcomes. The associated delay with immuni-
sation has been previously reported [32,34,35] and in
fact not unexpected as antenatal clinics are the
conventional platforms for educating pregnant women
on the benefits of childhood immunisation. Mothers
who did attend antenatal clinics were unlikely to use
nutritional supplements which are freely provided as
part of antenatal care in this population. This factor
along with lack of counselling on proper infant feeding
practices may underpin the observed association
between infant’s undernourishment and immunisation
delays. Although it made intuitive sense to expect delays
associated with lack of antenatal care to be greater
among multiparous women or those who delivered out-
side hospitals, no such evidence was found when inter-
actions among these terms were tested. A possible
reason could be due to the lack of details on the actual
number of antenatal visits made to allow for a more
robust multi-level testing for the other variables. For
example, the infants whose mothers received the WHO
recommended minimum of four antenatal visits were
significantly more likely to be associated with improved
immunisation uptake than those with less than four vis-
its [35]. It was also not unlikely that the increased risk
of delays among infants with multiple gestations who
were usually underweight was attributable to the com-
mon practice of keeping such infants at home until they
appeared strong enough (with added weight) to be pre-
sented at public places like immunisation clinics. The
decreased odds associated with caesarean delivery (pre-
dominantly non-elective) compared to normal/vaginal
delivery would suggest that affected mothers are more
likely to embrace postnatal services such as immunisa-
tion following the extended post delivery contact with
hospital services. Mothers with formal employment are
more likely to take advantage of the statutory 12 weeks
maternity leave before its expiration to obtain BCG
immunisation for their children as this may be difficult
once they returned to work.
Table 3 Predictors of BCG immunisation delays after multivariable logistic regression analyses
Factors Delays beyond 14 days Delays beyond 42 days
Adjusted
a odds ratio
(95% Confidence
interval)
Population attributable risk
(%)
Adjusted
b odds ratio
(95% Confidence
interval)
Population
attributable
risk (%)
Maternal
Employed (regular or part-time) - - 0.68 (0.51 - 0.89)** 0
No antenatal care(current
delivery)
- - 2.27 (1.37 - 3.75)*** 2.2
Delivery by caesarean section 0.29 (0.20 - 0.42)*** 0 - -
Infant
Multiple gestations - - 1.85 (1.07 - 3.19)* 1.5
Treated for neonatal jaundice 0.55 (0.42 - 0.72)*** 0 0.28 (0.15 - 0.52)*** 0
Undernourished
c 1.70 (1.45 - 2.09)*** 18.7 1.74 (1.45 - 2.09)*** 20.8
aAdjusted for maternal education, occupation, place of delivery, hospital admission and other covariates.
bAdjusted for place of delivery, preterm birth and other covariates.
c Based on z-scores for weight-for-age, height/length-for-age or body-mass-index of less than
-2 singly or in combination, using WHO 2006 Growth Standards.
21 *p < 0.05; **p < 0.01; ***p < 0.001
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Page 8 of 10Although place of birth was associated with delays in
the bivariate analyses in line with the significant differ-
ence observed in the survival analysis, this factor was
not predictive of delays after adjusting for other con-
founding variables. A similar pattern was reported in
one study from Malawi [29] while another from China
found home birth to be independently predictive of
immunisation delays [28]. It is not uncommon for birth
order to be associated with immunisation delays
[6,7,28,34,35] but no such evidence was found in this
study in line with some other studies [29].
Notwithstanding the strengths and uniqueness of this
study, the extent to which the findings can be generalised
to the rest of the country and other communities in sub-
Saharan Africa appears uncertain considering some addi-
tional limitations of the study. For example, it was diffi-
cult to estimate the number of infants who were not
taken to the immunisation clinics in the community due
to the lack of vital registration data from the local health
a u t h o r i t y .W h e r es u c hd a t ae x i s ti tm a yt h e nb ew o r t h -
while to explore the possibility of a tracking system based
on mobile phone which is now commonly used in many
urban areas to detect and follow up defaulting mothers
through text messages. Selection bias was not improbable
as this study was limited to four of the seven BCG clinics
in the community even though they potentially
accounted for 75% of all BCG immunisation. The study
design also precluded comparison with other immunisa-
tions scheduled within the first three months while no
detailed information was available on infants older than 3
months regardless of their immunisation status. In addi-
tion, parents and the health workers were not inter-
viewed to ascertain possible reasons for delays or default
such as illness of the mother/child and other unavoidable
constraints as well as the potential contribution of ser-
vice-related factors such as rescheduling due to vaccine
shortage, waiting time and convenience of visits. None-
theless, this study has further demonstrated the need to
pay attention to timeliness of reported immunisation
coverage in evaluating the performance of BCG immuni-
sation. It has also highlighted important but modifiable
predictors and early markers of childhood immunisation
delays in this region that will facilitate improved services
for routine BCG immunisation and forestall potential
snowballing of delays to subsequent immunisation in
early childhood. Improved uptake of antenatal care
should provide a platform for supporting mothers early
to address some of these factors.
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